A non-invasive transport system for GDNF across the blood-brain barrier.

@article{Albeck1997ANT,
  title={A non-invasive transport system for GDNF across the blood-brain barrier.},
  author={David S Albeck and Barry J. Hoffer and David O. Quissell and Linda A. Sanders and Gary Zerbe and Ann-Charlotte E. Granholm},
  journal={Neuroreport},
  year={1997},
  volume={8 9-10},
  pages={2293-8}
}
Glial cell line-derived neurotrophic factor (GDNF) is a neurotrophin which supports midbrain dopaminergic neurons and spinal cord motorneurons. GDNF has been proposed as a possible therapeutic agent for Parkinson's disease, spinal cord injury or motorneuron degenerative disorders. Administration of GDNF is complicated by its poor penetration across the blood-brain barrier (BBB). Central nervous system capillaries are uniquely enriched in transferrin receptors and antibodies to these receptors… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

GDNF--a potential target to treat addiction.

Pharmacology & therapeutics • 2009
View 1 Excerpt

Prolonged modulation of FGF-2 expression in astrocytic cultures induced by O,O'-diacetyl-apomorphine.

Biochemical and biophysical research communications • 2008
View 1 Excerpt

Similar Papers

Loading similar papers…